These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7881986)

  • 21. Red cell ferritin, a marker of iron deficiency in hemodialysis patients.
    Bhandari S; Owda AK; Kendall RG; Moran N; Norfolk DR; Brownjohn AM; Turney JH
    Ren Fail; 1997 Nov; 19(6):771-80. PubMed ID: 9415934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of iron-deficiency anaemia.
    Cook JD
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):319-32. PubMed ID: 15737893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron status as measured by serum ferritin: the marker and its limitations.
    Cavill I
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S12-7. PubMed ID: 10516370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron metabolism and iron substitution during erythropoietin therapy.
    Sunder-Plassmann G; Hörl WH
    Clin Investig; 1994; 72(6 Suppl):S11-5. PubMed ID: 7950165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin, iron metabolism, and red blood cell production.
    Adamson J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era.
    Kalantar-Zadeh K; Höffken B; Wünsch H; Fink H; Kleiner M; Luft FC
    Am J Kidney Dis; 1995 Aug; 26(2):292-9. PubMed ID: 7645533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of iron deficiency in chronic renal failure.
    Fernández-Rodríguez AM; Guindeo-Casasús MC; Molero-Labarta T; Domínguez-Cabrera C; Hortal-Casc n L; Pérez-Borges P; Vega-Díaz N; Saavedra-Santana P; Palop-Cubillo L
    Am J Kidney Dis; 1999 Sep; 34(3):508-13. PubMed ID: 10469862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoiesis and iron.
    Cavill I
    Best Pract Res Clin Haematol; 2002 Jun; 15(2):399-409. PubMed ID: 12401314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome.
    Matzkies FK; Cullen P; Schaefer L; Hartmann M; Hohage H; Schaefer RM
    South Med J; 1999 Dec; 92(12):1157-61. PubMed ID: 10624905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
    Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiency.
    Murphy PT; Quinn JP; O'Donghaile D; Swords R; O'Donnell JR
    Ann Hematol; 2006 Jul; 85(7):455-7. PubMed ID: 16568320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythrocyte zinc protoporphyrin.
    Braun J
    Kidney Int Suppl; 1999 Mar; 69():S57-60. PubMed ID: 10084287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study.
    Breymann C; Major A; Richter C; Huch R; Huch A
    J Perinat Med; 1995; 23(1-2):89-98. PubMed ID: 7658327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron and the anemia of chronic disease.
    Spivak JL
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):25-33. PubMed ID: 12380952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
    Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
    Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.